| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: ASCO |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Regeneron |
| Recipient: Your Institution |
| Company: OncoMed |
| Recipient: Your Institution |
| Company: Incyte |
| Recipient: Your Institution |
| Company: CicloMed |
| Recipient: Your Institution |
| Company: Mersana |
| Recipient: Your Institution |
| Company: Astex Pharmaceuticals |
| Recipient: Your Institution |
| Company: Abbvie |
| Recipient: Your Institution |
| Company: Takeda |
| Recipient: Your Institution |
| Company: Celgene |
| Recipient: Your Institution |
| Company: Merck |
| Recipient: Your Institution |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: G1 Therapeutics |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Revolution Medicines |
| Recipient: Your Institution |
| Company: Boehringer Ingelheim |
| Recipient: Your Institution |
| Company: ArQule |
| Recipient: Your Institution |
| Company: Bristol-Myers Squibb |
| Recipient: Your Institution |
| Company: Klus Pharma, Inc |
| Recipient: Your Institution |
| Company: Tesaro |
| Recipient: Your Institution |
| Company: Macrogenics |
| Recipient: Your Institution |
| Company: evelo biosciences |
| Recipient: Your Institution |
| Company: Tarveda Therapeutics |
| Recipient: Your Institution |
| Company: tempest |
| Recipient: Your Institution |
| Company: Vigeo |
| Recipient: Your Institution |
| Company: atreca |
| Recipient: Your Institution |
| Company: IgM Biosciences |
| Recipient: Your Institution |
| Company: Synermore biologics |
| Recipient: Your Institution |
| Company: Exelexis |
| Recipient: Your Institution |
| Company: Takeda |
| Recipient: Your Institution |
| Company: GlaxoSmithKline |
| Recipient: Your Institution |
| Company: Erasca, Inc |
| Recipient: Your Institution |
| Company: Adlai Nortye |
| Recipient: Your Institution |
| Company: NGM Biopharmaceuticals |
| Recipient: Your Institution |
| Company: Exelixis |
| Recipient: Your Institution |
| Company: Pionyr |
| Recipient: Your Institution |
| Company: immunitas |
| Recipient: Your Institution |
| Company: Artios |
| Recipient: Your Institution |
| Company: Eisai |
| Recipient: Your Institution |
| Company: Jazz Pharmaceuticals |
| Recipient: Your Institution |
| Company: Jazz Pharmaceuticals |
| Recipient: Your Institution |
| Company: Omega Therapeutics |
| Recipient: Your Institution |
| Company: Purple Biotech |
| Recipient: Your Institution |
| Company: Theradex |
| Recipient: Your Institution |
| Company: Totus Medicines |
| Recipient: Your Institution |
| Company: Tvardi Therapeutics |
| Recipient: Your Institution |
| Company: Tvardi Therapeutics |
| Recipient: Your Institution |
| Company: Qurgen |
| Recipient: Your Institution |
| Company: Exthera medical |
| Recipient: Your Institution |
| Company: Sapience Therapeutics |
| Recipient: Your Institution |
| Company: artios |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|